Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 54

Results For "disease"

3231 News Found

Union Health Secretary reviews Swachhata Pakhwada at AIIMS Mangalagiri
Policy | April 10, 2026

Union Health Secretary reviews Swachhata Pakhwada at AIIMS Mangalagiri

Punya Salila Srivastava commends sanitation, waste management and infection control measures, while inaugurating a new G+9 undergraduate girls’ hostel


Exclusive | Bharat Biotech’s ROTAVAC halves severe diarrhoea hospitalisations in children, landmark Nature study confirms
Biopharma | April 10, 2026

Exclusive | Bharat Biotech’s ROTAVAC halves severe diarrhoea hospitalisations in children, landmark Nature study confirms

Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP


Cadila Pharma launches triple-combination therapy for stronger BP control
News | April 10, 2026

Cadila Pharma launches triple-combination therapy for stronger BP control

The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms


BC Jindal Foundation to raise healthcare CSR investment to Rs 16 crore in FY27
News | April 10, 2026

BC Jindal Foundation to raise healthcare CSR investment to Rs 16 crore in FY27

The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces


Sharda Hospital performs Greater Noida’s first kidney transplant Under Ayushman Bharat
Hospitals | April 09, 2026

Sharda Hospital performs Greater Noida’s first kidney transplant Under Ayushman Bharat

Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care


University of Leeds launches landmark HALO study on lifelong impact of childhood blood disorders
Hospitals | April 09, 2026

University of Leeds launches landmark HALO study on lifelong impact of childhood blood disorders

Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust


India’s Dapagliflozin Moment: Why USFDA’s generic greenlight wave matters
Drug Approval | April 09, 2026

India’s Dapagliflozin Moment: Why USFDA’s generic greenlight wave matters

In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga


Halozyme strikes global deal with Vertex to expand Hypercon drug delivery technology
Technology | April 09, 2026

Halozyme strikes global deal with Vertex to expand Hypercon drug delivery technology

The deal gives Vertex access to Halozyme’s Hypercon technology for up to three drug targets


Insmed’s Brensocatib fails to hit endpoints in hidradenitis suppurativa study
News | April 09, 2026

Insmed’s Brensocatib fails to hit endpoints in hidradenitis suppurativa study

The results were consistent across both the 10 mg and 40 mg treatment arms


WHO updates global guidelines to combat opioid crisis
Healthcare | April 08, 2026

WHO updates global guidelines to combat opioid crisis

Opioid dependence remains a major driver of death and disease worldwide